Shi Yang, MD

Associate Professor, Pathology & Laboratory Medicine

Shi Yang
617.414.5057
670 Albany St Biosquare III

Biography

Expertise in molecular pathology.

Other Positions

  • Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Division of Graduate Medical Sciences

Education

  • Hebei Medical College, MM
  • China Academy of Chinese Medical Sciences (CACMS), MB
  • Hebei Medical College, BS

Publications

  • Published on 7/3/2018

    de la Cueva A, Emmerling M, Lim SL, Yang S, Trackman PC, Sonenshein GE, Kirsch KH. A polymorphism in the lysyl oxidase propeptide domain accelerates carcinogen-induced cancer. Carcinogenesis. 2018 Jul 03; 39(7):921-930. PMID: 29579155.

    Read at: PubMed
  • Published on 5/6/2018

    Alekseyev YO, Fazeli R, Yang S, Basran R, Maher T, Miller NS, Remick D. A Next-Generation Sequencing Primer-How Does It Work and What Can It Do? Acad Pathol. 2018 Jan-Dec; 5:2374289518766521. PMID: 29761157.

    Read at: PubMed
  • Published on 1/13/2017

    Frydenlund N, Leone D, Yang S, Hoang MP, Deng A, Hernandez-Perez M, Singh R, Biswas A, Yaar R, Mahalingam M. Tumoral PD-L1 expression in desmoplastic melanoma is associated with depth of invasion, tumor-infiltrating CD8 cytotoxic lymphocytes and the mixed cytomorphological variant. Mod Pathol. 2017 Mar; 30(3):357-369. PMID: 28084337.

    Read at: PubMed
  • Published on 1/1/2017

    Josenia Tan, Antonio de las Morenas , Shi Yang and Huihong Xu. Comparison of the clinicopathologic features of solitary and multifocal papillary thyroid carcinoma and the utility of testing an additional tumor nodule for BRAFV600E in multifocal cases. J Mod Hum Pathol. 2017; 2(1):1-6.

    Read at: Custom
  • Published on 11/15/2016

    Mitchell B, Leone D, Yang S, Khan A, Mahalingam M, Dhingra J. BRAF and epithelial-mesenchymal transition in papillary thyroid carcinoma - challenging the roles of Snail and E-Cadherin? Am J Transl Res. 2016; 8(11):5076-5086. PMID: 27904709.

    Read at: PubMed
  • Published on 8/1/2016

    Yang S, Leone D, Frydenlund N, Hoang M, Deng A, Hernandez-Perez M, Biswas A, Singh R, Yaar R, Mahalingam M. Frequency of telomerase reverse transcripter promoter mutations in desmoplastic melanoma subtypes: analyses of 76 cases. Melanoma Res. 2016 Aug; 26(4):361-6. PMID: 27244099.

    Read at: PubMed
  • Published on 3/9/2016

    Kadokura A, Frydenlund N, Leone DA, Yang S, Hoang MP, Deng A, Hernandez-Perez M, Biswas A, Singh R, Yaar R, Mahalingam M. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver? Hum Pathol. 2016 Jul; 53:82-90. PMID: 26980030.

    Read at: PubMed
  • Published on 2/1/2016

    Mitchell B, Leone DA, Feller JK, Yang S, Mahalingam M. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin? Hum Pathol. 2016 Jun; 52:19-27. PMID: 26980024.

    Read at: PubMed
  • Published on 11/1/2015

    Chung HJ, Yang S, Succaria F, Bhawan J. Telomerase (TERT) promoter mutations are infrequent in Merkel cell carcinomas. J Am Acad Dermatol. 2015 Nov; 73(5):864-5. PMID: 26475538.

    Read at: PubMed
  • Published on 3/7/2015

    Frydenlund N, Leone DA, Mitchell B, Yang S, Deng A, Hoang MP, Mahalingam M. Neurotrophin receptors and perineural invasion in desmoplastic melanoma. J Am Acad Dermatol. 2015 May; 72(5):851-8. PMID: 25752716.

    Read at: PubMed

View 41 more publications: View full profile at BUMC

View all profiles